Youssef Bennani

Youssef Bennani's work experience is as follows:

- Youssef Bennani is currently the Managing Partner at CTI Life Sciences Fund since May 2021.

- Prior to that, they served as the CSO at adMare BioInnovations and was a Board member from February 2020 to the present.

- Youssef was also a Venture Partner at adMare BioInnovations from April 2019 to February 2020.

- Youssef Bennani has been a Board Member at Bellus Health since April 2017, and their term is expected to end in June 2023.

- Youssef has been the Chairman of the Board of Directors at DOMAIN Therapeutics since April 2014, and their term is expected to end in April 2023.

- Youssef Bennani was the Chief Executive Officer at Find Therapeutics from May 2020 to February 2022.

- Youssef has held various roles at Vertex Pharmaceuticals, including Site Head & VP R&D from August 2011 to March 2018, and Vice-President-Drug Innovation from September 2004 to August 2011.

Youssef Bennani has a diverse education background. Youssef holds a Ph.D. in Medicinal and Pharmaceutical Chemistry from the Université de Montréal (UdeM), as well as an MBA from McGill University and a degree in Corporate Governance from Lake Forest Graduate School of Management (LFGSM). Additionally, they completed a post-doctoral program in Organic Chemistry at Scripps Research. Earlier in their academic journey, they obtained a B.Sc., M.Sc., and Ph.D. in Chemistry from Université de Montréal. Overall, Youssef's educational focus has been on chemistry, business, and corporate governance.